Amyotrophic Lateral Sclerosis (HAS)

In 2006, the HAS published a conference report concerning the Amyotrophic Lateral Sclerosis (ALS), or maladie de Charcot. This disease is characterised by a paralysis of the labial, glottal, pharyngeal, laryngeal limbs and muscles resulting from progressive degeneration of neurons.

ALS Diagnosis

First symptoms

  • This HAS document emphasizes that symptoms lie on the combination of symptoms involving the peripheral motor neurons and the central motor neurons :
    • Motor deficiency of one or several limbs;
    • Muscular atrophy and pain;
    • Cramps ;
    • Fasciculation (involuntary muscular contractions) ;
    • Difficulties to walk, stiffness, repetitive sprains ;
    • Decrease of muscular tonus ;
    • Swallowing disorders, dysphonia and dysarthria ;
    • Salivation stasis;
    • Spasmodic laughter or cry, phonation, swallowing disorders, exaggeration of nausea reflexes, yawing
    • Chin clonus, automatic voluntary dissociation of the velum palatinum.
  • Other signs :
    • Sensatory disorders,
    • Oculo-motors paralysis,
    • Sphincterian disorders,
    • Marked cognitive disorders.
  • Differential diagnosis according to the clinical and familial context, clinical presentation and related pathologies.

Genetic inquiry

  • A genetic inquiry is recommended in case of:
    • An hereditary form including at least 2 cases even over several generations,
    • Unusual clinical form (Kennedy disease, spinal amyotrophy for adult, juvenile ALS before the age of 20)
    • Dementia related ALS.

ALS Evaluation

  • This HAS document states that it must :
    • Be regular,
    • State the physical condition of the patient and its requests,
    • Allow forseeing the evolution of the disability.
  • It includes:
    • Interview: family, professional, social status and place of living;
    • Assessment of motor and psychological incapacities,
    • Manual muscular testing;
    • Orthophonic check-up: dysarthria, swallowing, communication ;
    • Supervising nutrition status: BMI, weight, fat mass;
    • Impairment of sleeping quality and quantity;
    • Dyspnoea, orthopnea , bronchial congestion.

Therapy and follow up

Medicinal therapy

  • Etiologic aim :
    • Administration of riluzole,
      • Increase survival,
      • Delay the use of mechanic ventilation.
  • Symptomatic:
    • Muscular pains:
      • Quinine,
      • Kinesitherapy ,
    • Salivation disorders:
      • Stasis: tricyclic, scopolamine, A botulinum toxin or radiotherapy;
      • Modification of salivation consistency: beta adrenergic blocking agent;
      • Spasticity : baclofen, tizanidine, dantrolen or benzodiazepines;
      • Emotional lability: tricyclic or inhibitors of the serotonin recapture;
    • Sleeping disorders: antihistaminic or hypnotic.

Non medicinal therapy

  • Physiotherapy:
    • Orthopedic,
    • Kinesitherapy.
  • Assisting the organisation of the patient's environment:
    • Orthosis,
    • Health aid,
    • Appropriate medical equipments.
  • Hygiene and comfort care, feeding assistance.
  • Psychological support of the patient and his relatives.
  • Substitution to breathing and nutrition fonctions.


Caring about people suffering from amyotrophic lateral sclerosis, HAS, 2006.

Photographic copyright: Oguzaral
CCM is a leading international tech website. Our content is written in collaboration with IT experts, under the direction of Jeff Pillou, founder of CCM reaches more than 50 million unique visitors per month and is available in 11 languages.